| |
Non-DM group
|
DM2 group
|
P
|
|---|
|
Patient no.
|
870
|
258
| |
|
Combined CAD (%)
| | |
0.052
|
|
None
|
102 (11.7)
|
15 (5.8)
| |
|
Single vessel
|
173 (19.9)
|
43 (16.7)
| |
|
Double vessels
|
222 (25.5)
|
78 (30.2)
| |
|
Three vessels
|
295 (33.9)
|
99 (38.4)
| |
|
LM only
|
3 (0.3)
|
0 (0.0)
| |
|
LM + single vessel
|
6 (0.7)
|
2 (0.8)
| |
|
LM + double vessels
|
13 (1.5)
|
1 (0.4)
| |
|
LM + three vessels
|
56 (6.4)
|
20 (7.8)
| |
|
SYNTAX score
|
14.00 [7.00, 21.00]
|
15.50 [8.25, 22.00]
|
0.048
|
|
SYNTAX score level (%)
| | |
0.376
|
|
Low (≤ 22)
|
668 (76.8)
|
195 (75.6)
| |
|
Mid (> 22 and ≤ 32)
|
166 (19.1)
|
47 (18.2)
| |
|
High (> 32)
|
36 (4.1)
|
16 (6.2)
| |
|
LM ectasia
|
108 (12.4)
|
23 (8.9)
|
0.153
|
|
LAD ectasia
|
363 (41.7)
|
110 (42.6)
|
0.85
|
|
LCX ectasia
|
333 (38.3)
|
97 (37.6)
|
0.901
|
|
RCA ectasia
|
540 (62.1)
|
146 (56.6)
|
0.131
|
|
Markis classification
| | |
0.06
|
|
Type I
|
63 (7.2)
|
9 (3.5)
| |
|
Type II
|
185 (21.3)
|
59 (22.9)
| |
|
Type III
|
223 (25.6)
|
56 (21.7)
| |
|
Type IV
|
399 (45.9)
|
134 (51.9)
| |
|
Diffuse dilation
|
472 (54.3)
|
124 (48.1)
|
0.093
|
|
Focal dilation (aneurysms)
|
398 (45.7)
|
134 (51.9%)
|
0.093
|
|
Big CAE (max diameter > 5 mm)
|
577 (66.3)
|
147 (57.0)
|
0.007
|
|
Contrast agent stasis
|
236 (27.1)
|
56 (21.7)
|
0.096
|
|
Thrombus in dilated segment
|
16 (1.8)
|
4 (1.6)
|
0.968
|
|
Calcification in dilated segment
|
52 (6.0)
|
23 (8.9)
|
0.128
|
|
Max. lesion diameter
|
5.47 [4.67, 6.29]
|
5.26 [4.46, 5.98]
|
0.004
|
|
Max. lesion length
|
31.34 [13.32, 62.97]
|
25.20 [10.39, 46.76]
|
0.002
|
- Values are mean ± SD, n (%), or median [interquartile range] unless otherwise stated
- CAD coronary artery disease; CAE coronary artery ectasia; LAD left anterior descending artery; LCX left circumflex artery; LM left main; RCA right coronary artery; SYNTAX synergy between PCI with Taxus and Cardiac Surgery
